Marketed as a next-generation agent in its class (often compared to the SARM or metabolic modulator families, depending on the source), Samast-6 has generated quiet interest in biohacking and niche pharmacology circles. It is not approved for human consumption by the FDA, MHRA, or EMA, and is sold strictly for in-vitro research.
Rating: ★★☆☆☆ (2.5/5)
Samast-6 shows significant promise in its primary mechanism, but a lack of transparent safety data, inconsistent synthesis quality, and minimal user feedback make it a high-risk choice for all but the most experienced researchers.